Literature DB >> 26383669

Draft Genome Sequence of Turicella otitidis TD1, Isolated from a Patient with Bacteremia.

Alexander L Greninger1, Varvara Kozyreva1, Chau-Linda Truong1, Margot Graves1, Vishnu Chaturvedi2.   

Abstract

We report the draft genome sequence of Turicella otitidis strain TD1, isolated from a central line catheter sample from a patient with a history of bowel obstruction. It contained several genetic determinants of multidrug-resistant phenotypes such as a cfrA 50S methyltransferase, two major facilitator superfamily-type drug resistance transporters, and a putative beta-lactamase.
Copyright © 2015 Greninger et al.

Entities:  

Year:  2015        PMID: 26383669      PMCID: PMC4574374          DOI: 10.1128/genomeA.01060-15

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Turicella otitidis is a nonfermenting Gram-positive non-spore-forming rod usually isolated from ear exudates. The bacterium was described originally in 1994 from acute and chronic otitis media and has since been isolated from a posterior auricular abscess, mastoiditis, and blood (1–3). To date, only one case of bacteremia due to T. otitidis has ever been reported (3). Its association with otitis media is controversial, as it has been isolated from the external auditory canal of healthy subjects at ratios comparable to those noted when T. otitidis otitis media was diagnosed (4–6). Most isolates demonstrate high resistance to macrolides and lincosamides with associated 23S rRNA mutations (4, 7). As only one whole genome of T. otitidis had been sequenced previously, we sequenced the draft genome of T. otitidis strain TD1, isolated from a central line catheter tip culture. The isolate, and another one on the same patient, from the same source, that was submitted 3 months before, had previously been identified in our laboratory by biochemical and cellular fatty acid analysis. DNA from strain TD1 was extracted using the Promega Genomic DNA Wizard kit, and paired-end libraries were constructed using the Nextera XT kit. Sequences were adapted and quality (Q30) trimmed using Cutadapt, de novo assembled using SPAdes version 3.5, metagenomically screened with SURPI, and annotated via Prokka version 1.1, as described previously (8–12). A total of 739, 492 paired-end reads with an average length of 173 nucleotides were recovered after trimming. De novo assembly yielded 160 contigs covering a total of 2,150,112 bp with an N50 of 24,176 bp, a GC content of 71.2%, an average coverage of 54×, and a total of 1,866 annotated coding sequences. BLASTn of the assembled 16S sequence from strain TD1 against the NCBI WGS database aligned 99.35% to T. otiditis ATCC 51513 and had an average nucleotide identity of 98.75% to ATCC 51513, confirming the identity of the strain (13). Direct mapping of TD1 reads to ATCC 51513 revealed 20,176 variants between the two strains. De novo assembly of reads that failed to map to ATCC 51513 revealed a total of 85.4 kb unique sequence, including a locus of 50 kb containing >60 hypothetical protein-coding sequences with no nucleotide homology to the NT database that aligned <35% amino acid by BLASTx and HHPred to various mycobacterium phage protein sequences (14). Genes in the remaining loci not present in ATCC 51513 included an arylsulfatase, a cadmium-cobalt antiporter, a phosphate/phosphonate transporter operon, and a unique ABC transporter, with all predicted proteins having <65% amino acid identity to the closest species, Corynebacterium glycinophilum AJ 3170. Antibiotic resistance genes annotated by the Comprehensive Antibiotic Resistance Database included a cfrA 50S methyltransferase (99% amino acid to T. otitidis ATCC 51513) and two major facilitator superfamily–type drug-resistance transporters (99% amino acid T. otitidis ATCC 51513 and 57 to 59% amino acid to Corynebacterium spp.) (15). In addition, a putative beta-lactamase aligned 93% by amino acid to T. otitidis ATCC 51513.

Nucleotide sequence accession number.

This whole-genome shotgun project has been deposited at DDBJ/EMBL/GenBank under the accession number LBNF00000000.
  14 in total

1.  Turicella otitidis as an unusual agent causing a posterior auricular abscess.

Authors:  S J Reynolds; M Behr; J McDonald
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

2.  Turicella otitidis in a bacteremic child with acute lymphoblastic leukemia.

Authors:  C Loïez; F Wallet; A Fruchart; M-O Husson; R J Courcol
Journal:  Clin Microbiol Infect       Date:  2002-11       Impact factor: 8.067

3.  Turicella otitidis and Corynebacterium auris do not cause otitis media with effusion in children.

Authors:  David Holzmann; Guido Funke; Thomas Linder; David Nadal
Journal:  Pediatr Infect Dis J       Date:  2002-12       Impact factor: 2.129

4.  The comprehensive antibiotic resistance database.

Authors:  Andrew G McArthur; Nicholas Waglechner; Fazmin Nizam; Austin Yan; Marisa A Azad; Alison J Baylay; Kirandeep Bhullar; Marc J Canova; Gianfranco De Pascale; Linda Ejim; Lindsay Kalan; Andrew M King; Kalinka Koteva; Mariya Morar; Michael R Mulvey; Jonathan S O'Brien; Andrew C Pawlowski; Laura J V Piddock; Peter Spanogiannopoulos; Arlene D Sutherland; Irene Tang; Patricia L Taylor; Maulik Thaker; Wenliang Wang; Marie Yan; Tennison Yu; Gerard D Wright
Journal:  Antimicrob Agents Chemother       Date:  2013-05-06       Impact factor: 5.191

5.  Prokka: rapid prokaryotic genome annotation.

Authors:  Torsten Seemann
Journal:  Bioinformatics       Date:  2014-03-18       Impact factor: 6.937

6.  Two Rapidly Growing Mycobacterial Species Isolated from a Brain Abscess: First Whole-Genome Sequences of Mycobacterium immunogenum and Mycobacterium llatzerense.

Authors:  Alexander L Greninger; Charles Langelier; Gail Cunningham; Chris Keh; Michael Melgar; Charles Y Chiu; Steve Miller
Journal:  J Clin Microbiol       Date:  2015-04-29       Impact factor: 5.948

Review 7.  Clinical microbiology of coryneform bacteria.

Authors:  G Funke; A von Graevenitz; J E Clarridge; K A Bernard
Journal:  Clin Microbiol Rev       Date:  1997-01       Impact factor: 26.132

8.  Turicella otitidis mastoiditis in a healthy child.

Authors:  A Dana; R Fader; D Sterken
Journal:  Pediatr Infect Dis J       Date:  2001-01       Impact factor: 2.129

9.  Resistance to macrolides by ribosomal mutation in clinical isolates of Turicella otitidis.

Authors:  Leyla Boumghar-Bourtchai; Hubert Chardon; Brigitte Malbruny; Senda Mezghani; Roland Leclercq; Anne Dhalluin
Journal:  Int J Antimicrob Agents       Date:  2009-05-02       Impact factor: 5.283

10.  A cloud-compatible bioinformatics pipeline for ultrarapid pathogen identification from next-generation sequencing of clinical samples.

Authors:  Samia N Naccache; Scot Federman; Narayanan Veeraraghavan; Matei Zaharia; Deanna Lee; Erik Samayoa; Jerome Bouquet; Alexander L Greninger; Ka-Cheung Luk; Barryett Enge; Debra A Wadford; Sharon L Messenger; Gillian L Genrich; Kristen Pellegrino; Gilda Grard; Eric Leroy; Bradley S Schneider; Joseph N Fair; Miguel A Martínez; Pavel Isa; John A Crump; Joseph L DeRisi; Taylor Sittler; John Hackett; Steve Miller; Charles Y Chiu
Journal:  Genome Res       Date:  2014-06-04       Impact factor: 9.043

View more
  1 in total

Review 1.  Reviewing the Pathogenic Potential of the Otitis-Associated Bacteria Alloiococcus otitidis and Turicella otitidis.

Authors:  Rachael Lappan; Sarra E Jamieson; Christopher S Peacock
Journal:  Front Cell Infect Microbiol       Date:  2020-02-14       Impact factor: 5.293

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.